Contact
Please use this form to send email to PR contact of this press release:
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
TO:
Please use this form to send email to PR contact of this press release:
Paratek Announces Positive Phase 3 Study of Omadacycline in Community-Acquired Bacterial Pneumonia
TO: